Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global LFA-based Cardiac Marker Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Troponin
1.2.3 CK-MB
1.2.4 Myoglobin
1.2.5 Others
1.3 Market by Application
1.3.1 Global LFA-based Cardiac Marker Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Laboratory Testing
1.3.3 Point-of-care Testing
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global LFA-based Cardiac Marker Market Perspective (2018-2033)
2.2 LFA-based Cardiac Marker Growth Trends by Region
2.2.1 Global LFA-based Cardiac Marker Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 LFA-based Cardiac Marker Historic Market Size by Region (2018-2023)
2.2.3 LFA-based Cardiac Marker Forecasted Market Size by Region (2024-2033)
2.3 LFA-based Cardiac Marker Market Dynamics
2.3.1 LFA-based Cardiac Marker Industry Trends
2.3.2 LFA-based Cardiac Marker Market Drivers
2.3.3 LFA-based Cardiac Marker Market Challenges
2.3.4 LFA-based Cardiac Marker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top LFA-based Cardiac Marker Players by Revenue
3.1.1 Global Top LFA-based Cardiac Marker Players by Revenue (2018-2023)
3.1.2 Global LFA-based Cardiac Marker Revenue Market Share by Players (2018-2023)
3.2 Global LFA-based Cardiac Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by LFA-based Cardiac Marker Revenue
3.4 Global LFA-based Cardiac Marker Market Concentration Ratio
3.4.1 Global LFA-based Cardiac Marker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by LFA-based Cardiac Marker Revenue in 2022
3.5 LFA-based Cardiac Marker Key Players Head office and Area Served
3.6 Key Players LFA-based Cardiac Marker Product Solution and Service
3.7 Date of Enter into LFA-based Cardiac Marker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 LFA-based Cardiac Marker Breakdown Data by Type
4.1 Global LFA-based Cardiac Marker Historic Market Size by Type (2018-2023)
4.2 Global LFA-based Cardiac Marker Forecasted Market Size by Type (2024-2033)
5 LFA-based Cardiac Marker Breakdown Data by Application
5.1 Global LFA-based Cardiac Marker Historic Market Size by Application (2018-2023)
5.2 Global LFA-based Cardiac Marker Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America LFA-based Cardiac Marker Market Size (2018-2033)
6.2 North America LFA-based Cardiac Marker Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America LFA-based Cardiac Marker Market Size by Country (2018-2023)
6.4 North America LFA-based Cardiac Marker Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe LFA-based Cardiac Marker Market Size (2018-2033)
7.2 Europe LFA-based Cardiac Marker Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe LFA-based Cardiac Marker Market Size by Country (2018-2023)
7.4 Europe LFA-based Cardiac Marker Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific LFA-based Cardiac Marker Market Size (2018-2033)
8.2 Asia-Pacific LFA-based Cardiac Marker Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2018-2023)
8.4 Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America LFA-based Cardiac Marker Market Size (2018-2033)
9.2 Latin America LFA-based Cardiac Marker Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America LFA-based Cardiac Marker Market Size by Country (2018-2023)
9.4 Latin America LFA-based Cardiac Marker Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa LFA-based Cardiac Marker Market Size (2018-2033)
10.2 Middle East & Africa LFA-based Cardiac Marker Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2018-2023)
10.4 Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher LFA-based Cardiac Marker Introduction
11.1.4 Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2018-2023)
11.1.5 Thermo Fisher Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Detail
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories LFA-based Cardiac Marker Introduction
11.2.4 Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2018-2023)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Becton, Dickinson
11.3.1 Becton, Dickinson Company Detail
11.3.2 Becton, Dickinson Business Overview
11.3.3 Becton, Dickinson LFA-based Cardiac Marker Introduction
11.3.4 Becton, Dickinson Revenue in LFA-based Cardiac Marker Business (2018-2023)
11.3.5 Becton, Dickinson Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche LFA-based Cardiac Marker Introduction
11.4.4 Roche Revenue in LFA-based Cardiac Marker Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Hologic
11.5.1 Hologic Company Detail
11.5.2 Hologic Business Overview
11.5.3 Hologic LFA-based Cardiac Marker Introduction
11.5.4 Hologic Revenue in LFA-based Cardiac Marker Business (2018-2023)
11.5.5 Hologic Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott LFA-based Cardiac Marker Introduction
11.6.4 Abbott Revenue in LFA-based Cardiac Marker Business (2018-2023)
11.6.5 Abbott Recent Development
11.7 Siemens
11.7.1 Siemens Company Detail
11.7.2 Siemens Business Overview
11.7.3 Siemens LFA-based Cardiac Marker Introduction
11.7.4 Siemens Revenue in LFA-based Cardiac Marker Business (2018-2023)
11.7.5 Siemens Recent Development
11.8 Danaher
11.8.1 Danaher Company Detail
11.8.2 Danaher Business Overview
11.8.3 Danaher LFA-based Cardiac Marker Introduction
11.8.4 Danaher Revenue in LFA-based Cardiac Marker Business (2018-2023)
11.8.5 Danaher Recent Development
11.9 Alere
11.9.1 Alere Company Detail
11.9.2 Alere Business Overview
11.9.3 Alere LFA-based Cardiac Marker Introduction
11.9.4 Alere Revenue in LFA-based Cardiac Marker Business (2018-2023)
11.9.5 Alere Recent Development
11.10 BioMérieux
11.10.1 BioMérieux Company Detail
11.10.2 BioMérieux Business Overview
11.10.3 BioMérieux LFA-based Cardiac Marker Introduction
11.10.4 BioMérieux Revenue in LFA-based Cardiac Marker Business (2018-2023)
11.10.5 BioMérieux Recent Development
11.11 LSI
11.11.1 LSI Company Detail
11.11.2 LSI Business Overview
11.11.3 LSI LFA-based Cardiac Marker Introduction
11.11.4 LSI Revenue in LFA-based Cardiac Marker Business (2018-2023)
11.11.5 LSI Recent Development
11.12 Clinical Diagnostics
11.12.1 Clinical Diagnostics Company Detail
11.12.2 Clinical Diagnostics Business Overview
11.12.3 Clinical Diagnostics LFA-based Cardiac Marker Introduction
11.12.4 Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2018-2023)
11.12.5 Clinical Diagnostics Recent Development
11.13 Randox laboratories
11.13.1 Randox laboratories Company Detail
11.13.2 Randox laboratories Business Overview
11.13.3 Randox laboratories LFA-based Cardiac Marker Introduction
11.13.4 Randox laboratories Revenue in LFA-based Cardiac Marker Business (2018-2023)
11.13.5 Randox laboratories Recent Development
11.14 Wondfo Biotech
11.14.1 Wondfo Biotech Company Detail
11.14.2 Wondfo Biotech Business Overview
11.14.3 Wondfo Biotech LFA-based Cardiac Marker Introduction
11.14.4 Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2018-2023)
11.14.5 Wondfo Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global LFA-based Cardiac Marker Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Troponin
Table 3. Key Players of CK-MB
Table 4. Key Players of Myoglobin
Table 5. Key Players of Others
Table 6. Global LFA-based Cardiac Marker Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global LFA-based Cardiac Marker Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global LFA-based Cardiac Marker Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global LFA-based Cardiac Marker Market Share by Region (2018-2023)
Table 10. Global LFA-based Cardiac Marker Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global LFA-based Cardiac Marker Market Share by Region (2024-2033)
Table 12. LFA-based Cardiac Marker Market Trends
Table 13. LFA-based Cardiac Marker Market Drivers
Table 14. LFA-based Cardiac Marker Market Challenges
Table 15. LFA-based Cardiac Marker Market Restraints
Table 16. Global LFA-based Cardiac Marker Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global LFA-based Cardiac Marker Market Share by Players (2018-2023)
Table 18. Global Top LFA-based Cardiac Marker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac Marker as of 2022)
Table 19. Ranking of Global Top LFA-based Cardiac Marker Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by LFA-based Cardiac Marker Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players LFA-based Cardiac Marker Product Solution and Service
Table 23. Date of Enter into LFA-based Cardiac Marker Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global LFA-based Cardiac Marker Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global LFA-based Cardiac Marker Revenue Market Share by Type (2018-2023)
Table 27. Global LFA-based Cardiac Marker Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global LFA-based Cardiac Marker Revenue Market Share by Type (2024-2033)
Table 29. Global LFA-based Cardiac Marker Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global LFA-based Cardiac Marker Revenue Market Share by Application (2018-2023)
Table 31. Global LFA-based Cardiac Marker Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global LFA-based Cardiac Marker Revenue Market Share by Application (2024-2033)
Table 33. North America LFA-based Cardiac Marker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America LFA-based Cardiac Marker Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America LFA-based Cardiac Marker Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe LFA-based Cardiac Marker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe LFA-based Cardiac Marker Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe LFA-based Cardiac Marker Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific LFA-based Cardiac Marker Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America LFA-based Cardiac Marker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America LFA-based Cardiac Marker Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America LFA-based Cardiac Marker Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa LFA-based Cardiac Marker Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2024-2033) & (US$ Million)
Table 48. Thermo Fisher Company Detail
Table 49. Thermo Fisher Business Overview
Table 50. Thermo Fisher LFA-based Cardiac Marker Product
Table 51. Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2018-2023) & (US$ Million)
Table 52. Thermo Fisher Recent Development
Table 53. Bio-Rad Laboratories Company Detail
Table 54. Bio-Rad Laboratories Business Overview
Table 55. Bio-Rad Laboratories LFA-based Cardiac Marker Product
Table 56. Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2018-2023) & (US$ Million)
Table 57. Bio-Rad Laboratories Recent Development
Table 58. Becton, Dickinson Company Detail
Table 59. Becton, Dickinson Business Overview
Table 60. Becton, Dickinson LFA-based Cardiac Marker Product
Table 61. Becton, Dickinson Revenue in LFA-based Cardiac Marker Business (2018-2023) & (US$ Million)
Table 62. Becton, Dickinson Recent Development
Table 63. Roche Company Detail
Table 64. Roche Business Overview
Table 65. Roche LFA-based Cardiac Marker Product
Table 66. Roche Revenue in LFA-based Cardiac Marker Business (2018-2023) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Hologic Company Detail
Table 69. Hologic Business Overview
Table 70. Hologic LFA-based Cardiac Marker Product
Table 71. Hologic Revenue in LFA-based Cardiac Marker Business (2018-2023) & (US$ Million)
Table 72. Hologic Recent Development
Table 73. Abbott Company Detail
Table 74. Abbott Business Overview
Table 75. Abbott LFA-based Cardiac Marker Product
Table 76. Abbott Revenue in LFA-based Cardiac Marker Business (2018-2023) & (US$ Million)
Table 77. Abbott Recent Development
Table 78. Siemens Company Detail
Table 79. Siemens Business Overview
Table 80. Siemens LFA-based Cardiac Marker Product
Table 81. Siemens Revenue in LFA-based Cardiac Marker Business (2018-2023) & (US$ Million)
Table 82. Siemens Recent Development
Table 83. Danaher Company Detail
Table 84. Danaher Business Overview
Table 85. Danaher LFA-based Cardiac Marker Product
Table 86. Danaher Revenue in LFA-based Cardiac Marker Business (2018-2023) & (US$ Million)
Table 87. Danaher Recent Development
Table 88. Alere Company Detail
Table 89. Alere Business Overview
Table 90. Alere LFA-based Cardiac Marker Product
Table 91. Alere Revenue in LFA-based Cardiac Marker Business (2018-2023) & (US$ Million)
Table 92. Alere Recent Development
Table 93. BioMérieux Company Detail
Table 94. BioMérieux Business Overview
Table 95. BioMérieux LFA-based Cardiac Marker Product
Table 96. BioMérieux Revenue in LFA-based Cardiac Marker Business (2018-2023) & (US$ Million)
Table 97. BioMérieux Recent Development
Table 98. LSI Company Detail
Table 99. LSI Business Overview
Table 100. LSI LFA-based Cardiac Marker Product
Table 101. LSI Revenue in LFA-based Cardiac Marker Business (2018-2023) & (US$ Million)
Table 102. LSI Recent Development
Table 103. Clinical Diagnostics Company Detail
Table 104. Clinical Diagnostics Business Overview
Table 105. Clinical Diagnostics LFA-based Cardiac Marker Product
Table 106. Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2018-2023) & (US$ Million)
Table 107. Clinical Diagnostics Recent Development
Table 108. Randox laboratories Company Detail
Table 109. Randox laboratories Business Overview
Table 110. Randox laboratories LFA-based Cardiac Marker Product
Table 111. Randox laboratories Revenue in LFA-based Cardiac Marker Business (2018-2023) & (US$ Million)
Table 112. Randox laboratories Recent Development
Table 113. Wondfo Biotech Company Detail
Table 114. Wondfo Biotech Business Overview
Table 115. Wondfo Biotech LFA-based Cardiac Marker Product
Table 116. Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2018-2023) & (US$ Million)
Table 117. Wondfo Biotech Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global LFA-based Cardiac Marker Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global LFA-based Cardiac Marker Market Share by Type: 2022 VS 2033
Figure 3. Troponin Features
Figure 4. CK-MB Features
Figure 5. Myoglobin Features
Figure 6. Others Features
Figure 7. Global LFA-based Cardiac Marker Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global LFA-based Cardiac Marker Market Share by Application: 2022 VS 2033
Figure 9. Laboratory Testing Case Studies
Figure 10. Point-of-care Testing Case Studies
Figure 11. LFA-based Cardiac Marker Report Years Considered
Figure 12. Global LFA-based Cardiac Marker Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global LFA-based Cardiac Marker Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global LFA-based Cardiac Marker Market Share by Region: 2022 VS 2033
Figure 15. Global LFA-based Cardiac Marker Market Share by Players in 2022
Figure 16. Global Top LFA-based Cardiac Marker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac Marker as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by LFA-based Cardiac Marker Revenue in 2022
Figure 18. North America LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America LFA-based Cardiac Marker Market Share by Country (2018-2033)
Figure 20. United States LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe LFA-based Cardiac Marker Market Share by Country (2018-2033)
Figure 24. Germany LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific LFA-based Cardiac Marker Market Share by Region (2018-2033)
Figure 32. China LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America LFA-based Cardiac Marker Market Share by Country (2018-2033)
Figure 40. Mexico LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa LFA-based Cardiac Marker Market Share by Country (2018-2033)
Figure 44. Turkey LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia LFA-based Cardiac Marker Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Thermo Fisher Revenue Growth Rate in LFA-based Cardiac Marker Business (2018-2023)
Figure 47. Bio-Rad Laboratories Revenue Growth Rate in LFA-based Cardiac Marker Business (2018-2023)
Figure 48. Becton, Dickinson Revenue Growth Rate in LFA-based Cardiac Marker Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in LFA-based Cardiac Marker Business (2018-2023)
Figure 50. Hologic Revenue Growth Rate in LFA-based Cardiac Marker Business (2018-2023)
Figure 51. Abbott Revenue Growth Rate in LFA-based Cardiac Marker Business (2018-2023)
Figure 52. Siemens Revenue Growth Rate in LFA-based Cardiac Marker Business (2018-2023)
Figure 53. Danaher Revenue Growth Rate in LFA-based Cardiac Marker Business (2018-2023)
Figure 54. Alere Revenue Growth Rate in LFA-based Cardiac Marker Business (2018-2023)
Figure 55. BioMérieux Revenue Growth Rate in LFA-based Cardiac Marker Business (2018-2023)
Figure 56. LSI Revenue Growth Rate in LFA-based Cardiac Marker Business (2018-2023)
Figure 57. Clinical Diagnostics Revenue Growth Rate in LFA-based Cardiac Marker Business (2018-2023)
Figure 58. Randox laboratories Revenue Growth Rate in LFA-based Cardiac Marker Business (2018-2023)
Figure 59. Wondfo Biotech Revenue Growth Rate in LFA-based Cardiac Marker Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed